Global X Genomics & Biotechn (GNOM) Technical Analysis
$10.87▲3.82%
Insights
- Global X Genomics & Biotechn is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Global X Genomics & Biotechn stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Global X Genomics & Biotechn stock is Range bound.
- Based on analysis of the Pivot Points, the current market trend for Global X Genomics & Biotechn stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 48.73 | Neutral |
Stochastic | 64.19, 74.32 | Neutral |
Ultimate Oscillator | 42.96 | Neutral |
Stochastic Relative Strength Index | 72.75, 83.63 | Neutral |
Moving Average Convergence Divergence | 0.01, -0.06 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 10.53 | Buy |
20 | 10.4 | Sell |
50 | 10.66 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 10.56 | Buy |
20 | 10.5 | Sell |
50 | 10.63 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 10.51 | Neutral |
20 | 10.32 | Buy |
50 | 10.63 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 10.67 | Buy |
20 | 10.49 | Buy |
50 | 10.43 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 10.75 | Buy |
20 | 10.62 | Buy |
50 | 10.32 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 11.0 |
Resistance L2 | 10.91 |
Resistance L1 | 10.8 |
Pivot Point | 10.71 |
Support L1 | 10.6 |
Support L2 | 10.51 |
Support L3 | 10.4 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.